Showing 741-750 of 1645 results for "".
- No Strings Attached: Is It Time to Sever Your Ties With Insurers?https://practicalneurology.com/columns/practice-management/no-strings-attached-is-it-time-to-sever-your-ties-with-insurers/31234/Navigating Medicare Reimbursement Cuts: The Shift Towards Cash-Only Practices in NeurologyThe December 2006 issue of *Practical Neurology* explores the profound effects of impending Medicare reimbursement reductions on neurologists. With a mandated five percent across-the-board cut effective in 2007
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31329/Advancements in Intracerebral Hemorrhage Management Highlighted in Practical NeurologyIntracerebral hemorrhage (ICH) constitutes approximately 15% of acute stroke cases, presenting a significant clinical challenge due to its high mortality rate of around 40% and substantial societal impact, accounti
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31339/At the February 2006 International Stroke Conference in Kissimmee, FL, leading vascular care experts convened to discuss advancements in stroke management and prevention. The event, hosted at the city’s convention center, facilitated the exchange of groundbreaking research and practical strategies a
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31400/Recent advancements in Alzheimer’s disease (AD) research are shedding light on its elusive etiology and pathophysiology, offering new insights for healthcare professionals. A significant study published in the *American Journal of Industrial Medicine* analyzed 2.6 million death records from 22 state
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0705epilepsy-pdf/31427/Sudden Unexpected Death in Epilepsy (SUDEP) remains a significant, though relatively uncommon, cause of mortality among individuals with epilepsy, particularly those with refractory seizures. SUDEP is defined as a sudden, unexpected, non-drowning, and non-traumatic death in a person with epilepsy, w
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0605EpilepsyEssentials-pdf/31439/Understanding the Intersection of Seizures, Hormones, and Women’s Health in Epilepsy ManagementDespite extensive research, the link between seizures, hormonal fluctuations, and women’s health remains underappreciated among many healthcare providers. A 2000 survey highlighted significant gaps in phys
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0605PainManagement-pdf/31444/In Practical Neurology’s latest issue, Dr. Charles Argoff presents a compelling case of a 56-year-old male accountant with no prior history of headaches, who experiences the sudden onset of right facial and head pain. The patient, otherwise healthy and leading a non-smoking, non-drinking lifestyle,
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31456/At the American Academy of Neurology’s 57th Annual Meeting in Miami Beach, numerous advancements in neurology were presented, offering valuable insights for healthcare professionals. A significant study by the Michael J. Fox Foundation involving 146,948 participants over 8.5 years revealed that regu
- How to Handle Hypersomniahttps://practicalneurology.com/diseases-diagnoses/sleep/pn0205pg26-33-pdf/31491/Sleep disorders are a critical yet often underappreciated aspect of neurological health, second only to essential needs like food and oxygen for survival. The International Classification of Sleep Disorders recognizes over 100 distinct sleep disorders, broadly categorized into hypersomnias, insomnia
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31495/Advancements in Alzheimer’s Disease Detection and TreatmentRecent strides in Alzheimer’s disease (AD) research offer promising avenues for early detection and potential treatment options, as highlighted in the latest findings shared by leading institutions. While a definitive biomarker for AD remain